Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

Journal of Experimental Medicine

Volumn 184, Issue 4, 1996, Pages 1513-1518

  Dowling, Peter ^a,b   Shang, Gaofeng ^a,b   Raval, Sumul ^b   Menonna, Joseph ^a,b   Cook, Stuart ^a,b   Husar, Walter ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WHITE MATTER;

ANTIGENS, CD95; BIOLOGICAL SPECIMEN BANKS; BRAIN; CELL DEATH; FAS LIGAND PROTEIN; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; NEUROGLIA; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 0029960673     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.4.1513     Document Type: Article

References (30)

1. ffrench-Constant, C. 1994. Pathogenesis of multiple sclerosis. Lancet. 343:271-275.
2. Hafler, D., and H. Weiner. 1995. Immunological mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144: 75-107.
3. Martin, R., and H. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:121-182.
4. Merrill, J., D. Kono, J. Clayton, D. Ando, D. Hinton, and F. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:574-579.
5. Rieckmann, P., M. Albrecht, B. Kitze, T. Weber, H. Tumani, A. Broocks, W. Luer, A. Helwig, and S. Poser. 1995. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:82-88.
6. Dowling, P., S. Bansil, J. Menonna, W. Husar, and S. Cook. 1995. Programmed cell death in multiple sclerosis brain. Ann. Neurol. 38:341. (Abstr.)
7. Gavrielli, Y., Y. Sherman, and S. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
8. Watanabe-Funkunaga, R., C. Brannan, N. Itoh, S. Yonehara, N. Copeland, N. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274-1279.
9. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K. Debatin, P. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
10. Matsuyama, T., R. Hata, M. Tagaya, Y. Yamamoto, T. Nakajima, J. Furuyama, A. Wanaka, and M. Sugita. 1994. Fas antigen mRNA induction in postischemic murine brain. Brain Res. 657:342-346.
11. Nishimura, T., H. Akiyama, S. Yonehara, H. Kondo, K. Okeda, M. Kato, E. Iseki, and K. Kosaka. 1995. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res. 695:135-145.
12. Tachibana, O., H. Nakazawa, J. Lampe, K. Watanabe, P. Kleihues, and H. Ohgaki. 1995. Expression of Fas/APO-1 during the progression of astrocytomas. Cancer Res. 55:5528-5530.
13. Weller, M., K. Frei, P. Groscurth, P. Krammer, Y. Yonekawa, and A. Fontana. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultures human glioma cells: induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:954-964.
14. Moller, P., K. Koretz, F. Leithauser, S. Bruderlein, C. Henne, A. Quentmeier, and P. Krammer. 1994. Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int. J. Cancer. 57: 371-377.
15. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
16. Tartaglia, L., T. Ayres, G. Wong, and D. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:845-853.
17. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell. 75:1168-1178.
18. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in T-cell lineage. J. Immunol. 154:3806-3813.
19. Griffith, T., T. Brunner, S. Fletcher, D. Green, and T. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science (Wash. DC). 270:1189-1192.
20. Bellgrau, D., D. Gold, H. Selaway, J. Moore, A. Franzosoff, and R. Duke. 1995. A role for CD95 ligand in preventing graft rejection. Nature (Lond.). 377:630-632.
21. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14:1129-1135.
22. Tanaka, M., T. Suda, K. Haze, N. Namura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga et al. 1996. Fas ligand in human serum. Nat. Med. 2:317-322.
23. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood. 84:1201-1208.
24. Galle, P., W. Hofman, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P. Krammer, and L. Runkel. 1995. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182:1223-1230.
25. Mita, E., N. Hayashi, S. Ito, T. Takehara, T. Hijioka, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Role of Fas ligand in apoptosis induced by Hepatitis C virus infection. Biochem. Biophys. Res. Commun. 204:468-474.
26. Dhein, J., H. Walczak, C. Baumer, K. Debatin, and P. Krammer. 1995. Autocrine T cell suicide mediated by APO-1 (Fas/CD95). Nature (Lond.). 373:438-441.
27. Brunner, T., R. Mogil, D. LaFace, N. Yoo, A. Mahoubl, F. Echeverri, S. Martin, W. Force, D. Lynch, C. Ware, and D. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
28. Ju, S.-T., D. Panka, H. Cul, R. Ettinger, M. El-Khabib, D. Sherr, B. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature (Lond.). 373:444-448.
29. Watanabe-Fukunaga, R., C. Brannan, N. Copeland, N. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
30. Enari, M., R. Talanian, W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.). 380:723-726.